{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Escobedo J"],"funding":["NHLBI NIH HHS"],"pagination":["41-6"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC2800289"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["85(1)"],"pubmed_abstract":["<h4>Objective</h4>To evaluate the effect of prior duration of diabetes, glycated hemoglobin level at study entry, and microalbuminuria or macroalbuminuria on the extent and severity of coronary artery disease (CAD) and peripheral arterial disease.<h4>Patients and methods</h4>We studied baseline characteristics of the 2368 participants of the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) study, a randomized clinical trial that evaluates treatment efficacy for patients with type 2 diabetes and angiographically documented stable CAD. Patients were enrolled from January 1, 2001, through March 31, 2005. Peripheral arterial disease was ascertained by an ankle-brachial index (ABI) of 0.9 or less, and extent of CAD was measured by presence of multivessel disease, a left v"],"journal":["Mayo Clinic proceedings"],"pubmed_title":["Association between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D study."],"pmcid":["PMC2800289"],"funding_grant_id":["U01 HL061744","U01 HL063804","U01 HL061746","U01 HL061748"],"pubmed_authors":["Robertson DG","Albert SG","Mooradian AD","Escobedo J","Rana JS","Srinivas VS","Gebhart SS","BARI 2D Study Group","Davis AM","Kennedy FP","Lombardero MS"],"additional_accession":[]},"is_claimable":false,"name":"Association between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D study.","description":"<h4>Objective</h4>To evaluate the effect of prior duration of diabetes, glycated hemoglobin level at study entry, and microalbuminuria or macroalbuminuria on the extent and severity of coronary artery disease (CAD) and peripheral arterial disease.<h4>Patients and methods</h4>We studied baseline characteristics of the 2368 participants of the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) study, a randomized clinical trial that evaluates treatment efficacy for patients with type 2 diabetes and angiographically documented stable CAD. Patients were enrolled from January 1, 2001, through March 31, 2005. Peripheral arterial disease was ascertained by an ankle-brachial index (ABI) of 0.9 or less, and extent of CAD was measured by presence of multivessel disease, a left v","dates":{"release":"2010-01-01T00:00:00Z","publication":"2010 Jan","modification":"2025-04-04T07:38:23.746Z","creation":"2019-03-27T00:27:42Z"},"accession":"S-EPMC2800289","cross_references":{"pubmed":["20042560"],"doi":["10.4065/mcp.2009.0265"]}}